Table 4 Comparison of general information and gene expressions between patients with and without pulmonary infection

Gender[cases (%)]

 Male

13(61.90)

3(75.00)

0.250

0.617

 Female

8(38.10)

1(25.00)

Age (\(\overline{x} \pm {\text{s}}\), years old)

71.33 ± 3.18

62.50 ± 3.42

5.037

 < 0.001

Smoking history[cases (%)]

 Yes

13(61.90)

1(25.00)

1.857

0.173

 No

8(38.10)

3(75.00)

Systolic pressures (\(\overline{x} \pm {\text{s}}\), mmHg)

177.76 ± 11.66

174.25 ± 7.80

0.573

0.572

Diastolic pressures (\(\overline{x} \pm {\text{s}}\), mmHg)

99.10 ± 11.52

102.25 ± 21.27

0.438

0.666

Diabetes[cases (%)]

12(57.14)

1(25.00)

1.391

0.238

Hyperlipidemia[cases (%)]

10(47.62)

1(25.00)

0.698

0.404

Coronary heart disease[cases (%)]

3(14.29)

0(0.00)

0.649

0.420

Hypertension course (\(\overline{x} \pm {\text{s}}\), years)

11.86 ± 3.24

12.00 ± 2.16

0.084

0.934

Cerebral hemorrhage volume (\(\overline{x} \pm {\text{s}}\), ml)

48.38 ± 11.14

45.50 ± 13.33

0.461

0.649

Gene expressions

 SPI1

0.63 ± 0.09

0.66 ± 0.13

0.502

0.620

 HK3

1.54 ± 0.19

1.17 ± 0.35

3.093

0.005

 HCK

1.51 ± 0.15

1.21 ± 0.14

3.581

0.002

 SYK

1.52 ± 0.16

1.28 ± 0.08

2.872

0.009

 CD14

1.53 ± 0.15

1.19 ± 0.03

4.434

 < 0.001

 FCER1G

1.71 ± 0.17

1.49 ± 0.03

2.581

0.017

 CYBB

1.48 ± 0.18

1.17 ± 0.08

3.268

0.003

 FGR

1.60 ± 0.16

1.29 ± 0.10

3.814

0.001